IGF-1 did not entirely reverse steatosis or some features of inflammation, however, supporting independent roles for both GH and IGF-1 in the pathogenesis of NAFLD and NASH [50,54,56]. This evidence concerns the gene IGF1 and metabolic dysfunction-associated steatotic liver disease.